QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Files Provisional Patent for Intranasal Drug Delivery Platform
Branded Legacy (OTC: BLEG), a holding company focused on innovative life sciences and wellness solutions, announced that its subsidiary BioLegacy Evaluative Group Inc. has filed a provisional patent application with the U.S. Patent and Trademark Office for its “Air-Driven Unitary Intranasal Drug Delivery Device for Stable and Reconstitutable Medicaments,” a compact, air-powered platform designed to provide precise, reliable, and cost-effective intranasal dosing for both stable formulations such as naloxone and unstable drugs requiring on-demand reconstitution. To view the full press release, visit https://ibn.fm/2uKdJ About Branded Legacy, Inc. Branded Legacy, Inc. (OTC: BLEG) is a forward-thinking holdings company dedicated to pioneering solutions in…